Browse by Journal Title

2022

Obesity, colorectal cancer and MACC1 expression: a possible novel molecular association.
Bähr, I., Jaeschke, L., Nimptsch, K., Janke, J., Herrmann, P., Kobelt, D., Kielstein, H., Pischon, T. and Stein, U.
International Journal of Oncology 60 (2): 17. February 2022

2015

Chemosensitization by diverging modulation by short-term and long-term TNF-α action on ABCB1 expression and NF-κB signaling in colon cancer.
Walther, W., Kobelt, D., Bauer, L., Aumann, J. and Stein, U.
International Journal of Oncology 47 (6): 2276-2285. December 2015

2010

Cell cycle effects of fatty acid derivatives of cytarabine, CP-4055, and of gemcitabine, CP-4126, as basis for the interaction with oxaliplatin and docetaxel.
Adema, A.D., Laan, A.C., Myhren, F., Fichtner, I., Verheul, H.M., Sandvold, M.L. and Peters, G.J.
International Journal of Oncology 36 (1): 285-294. 1 January 2010

2009

Localization of telomerase hTERT protein in frozen sections of basal cell carcinomas (BCC) and tumor margin tissues.
Fabricius, E.M., Kruse-Boitschenko, U., Khoury, R., Wildner, G.P., Raguse, J.D., Klein, M. and Hoffmeister, B.
International Journal of Oncology 35 (6): 1377-1394. December 2009

Efficacy of MS-275, a selective inhibitor of class I histone deacetylases, in human colon cancer models.
Bracker, T.U., Sommer, A., Fichtner, I., Faus, H., Haendler, B. and Hess-Stumpp, H.
International Journal of Oncology 35 (4): 909-920. October 2009

Immunohistochemical determination of the appropriate anti-hTERT antibodies for in situ detection of telomerase activity in frozen sections of head and neck squamous cell carcinomas and tumor margin tissues.
Fabricius, E.M., Kruse-Boitschenko, U., Khoury, R., Wildner, G.P., Raguse, J.D. and Klein, M.
International Journal of Oncology 34 (5): 1257-1279. May 2009

2006

The tumour-Clostridium phenomenon: 50 years of developmental research.
Schmidt, W., Fabricius, E.M. and Schneeweiss, U.
International Journal of Oncology 29 (6): 1479-1492. 1 December 2006

Anti-cancer effects of bortezomib against chemoresistant neuroblastoma cell lines in vitro and in vivo.
Michaelis, M., Fichtner, I., Behrens, D., Haider, W., Rothweiler, F., Mack, A., Cinatl, J., Doerr, H.W. and Cinatl, J.
International Journal of Oncology 28 (2): 439-446. February 2006

2003

Clinical significance of telomerase activity in basal cell carcinomas and in tumour-free surgical margins.
Fabricius, E.M., Bezeluk, A., Kruse-Boitschenko, U., Wildner, G.P. and Klein, M.
International Journal of Oncology 23 : 1389-1399. 1 November 2003

2002

Lack of protein kinase C (PKC)-beta and low PKC-alpha, -delta, -epsilon, and -zeta isozyme levels in proliferating human melanoma cells.
Krasagakis, K., Fimmel, S., Genten, D., Eberle, J., Quas, P., Ziegler, W., Haller, H. and Orfanos, C.E.
International Journal of Oncology 20 : 865-871. 1 January 2002

1997

Bromelain proteases suppress growth, invasion and lung metastasis of B16F10 mouse melanoma cells.
Grabowska, E., Eckert, K., Fichtner, I., Schulze-Forster, K. and Maurer, H.R.
International Journal of Oncology 11 : 243-248. 1 January 1997

Expression of E-cadherin/catenin complexes in breast cancer: correlation with favourable prognostic factors and survival.
Schoenborn, I., Zschiesche, W., Behrens, J., Herrenknecht, K. and Birchmeier, W.
International Journal of Oncology 11 : 1327-1334. 1 January 1997

1995

Influence of retrovirally transduced human tumor-necrosis-factor-alpha on the expression of C-myc, k-ras, C-jun, p53, tgf-alpha, and cea in human colon-carcinoma cell-lines.
Uckert, W., Walther, W. and Hummel, O.
International Journal of Oncology 6 : 1027-1031. 1 January 1995

1994

Induction of differentiation of human myeloid leukemic K562 cells by 3'-deoxy-3'-fluorothymidine (comparison with arabinosylcytosine).
Eckert, K., Fuhrmannselter, T., Schuett, M., Langen, P. and Maurer, H.R.
International Journal of Oncology 4 : 853-858. 1 January 1994

Amplification of satellite DNA at 16q11.2 in the germ line of a patient with breast cancer.
Savelyeva, L., Schneider, B., Finke, L.H., Schlag, P.M. and Schwab, M.
International Journal of Oncology 4 : 347-351. 1 January 1994

Wild-Type p53 is not involved in reversion of the tumorigenic phenotype of breast cancer cells after transfer of normal chromosome 17.
Theile, M., Hartmann, S., Naundorf, H., Ruebeta, D., Elbe, B., Krause, H., Deppert, W., Barrett, J.C. and Scherneck, S.
International Journal of Oncology 4 : 1067-1075. 1 January 1994

Influence of different promoters on the expression of tumor necrosis factor alpha in LS174T human colon carcinoma cells.
Uckert, W., Asche, O., Mahanty, B. and Fichtner, I.
International Journal of Oncology 5 : 865-871. 1 January 1994